This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
information resource reference
|
A multicenter phase II trial of the decitabine alternative 5-day dosing regimen: Analysis of efficacy in various subgroups of patients with myelodysplastic syndromes (MDS). J Clin Oncol. 2008 May 20; 26(15_suppl):7032.
|
|
label
|
A multicenter phase II trial of the decitabine alternative 5-day dosing regimen: Analysis of efficacy in various subgroups of patients with myelodysplastic syndromes (MDS).
|
- Myelodysplastic syndromes
- MDS